Noriyuki Okubo, Shingo Sugawara, Tohru Fujiwara, Ko Sakatsume, Tsuyoshi Doman, Mihoko Yamashita, Kota Goto, Masaki Tateishi, Misako Suzuki, Ryutaro Shirakawa, et al. VWF:RCo/VWF:Ag for diagnosis of acquired von Willebrand syndrome caused by aortic stenosis. Research and Practice in Thrombosis and Haemostasis. 2023. 102284-102284
Atsushi Kubo, Keisuke Hitachi, Ryutaro Shirakawa, Toshihiko Ogura. Protective effects of Mkl1/2 against lipodystrophy and muscle atrophy via PI3K/AKT-independent FoxO repression. bioRxiv. 2023
Koyu Ito, Kota Goto, Ryutaro Shirakawa, Hisanori Horiuchi, Kouetsu Ogasawara. Platelet αIIbβ3 integrin binds to SARS-CoV-2 spike protein of alpha strain but not wild type and omicron strains. Biochemical and Biophysical Research Communications. 2023. 657. 80-85
Mingxin Cao, Xinming Li, Duc-Anh Trinh, Shingo Yoshimachi, Kota Goto, Natsumi Sakata, Masaharu Ishida, Hideo Ohtsuka, Michiaki Unno, Yuxia Wang, et al. Ral GTPase promotes metastasis of pancreatic ductal adenocarcinoma via elevation of TGF-β1 production. The Journal of Biological Chemistry. 2023. 104754-104754
Shingo Yoshimachi, Ryutaro Shirakawa, Mingxin Cao, Duc Anh Trinh, Pan Gao, Natsumi Sakata, Kento Miyazaki, Kota Goto, Takayuki Miura, Kyohei Ariake, et al. Ral GTPase-activating protein regulates the malignancy of pancreatic ductal adenocarcinoma. Cancer Science. 2021
K. Saito, K. Sakatsume, R. Shirakawa, T. Kimura, M. Akiyama, Y. Saiki, H. Horiuchi. Accuired von Willebrand syndrome in patients treated with left ventricular assist devices. JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2015. 13. 744-744
H. Horiuchi, N. Yaoita, R. Shirakawa. Evaluation of activation states of small GTPases in patient platelets. JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2013. 11. 1139-1140
R. Saito, T. Kobayashi, M. Nakashima, Y. Matsui, N. Shibasaki, T. Inoue, H. Nishiyama, R. Shirakawa, H. Horiuchi, O. Ogawa. RalGAP, the Inactivator of Ral Small GTPase, Suppresses the Invasion and Metastasis of Prostate Cancer. UROLOGY. 2012. 80. 3. S278-S278
R. Saito, T. Kobayashi, M. Nakashima, Y. Matsui, N. Shibasaki, T. Kanno, T. Inoue, H. Nishiyama, R. Shirakawa, H. Horiuchi, et al. RalGAP, the inactivator of Ral small GTPase, suppresses the progression of prostate cancer. EUROPEAN UROLOGY SUPPLEMENTS. 2012. 11. 1. E839-U771